Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
345 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (2)
  • Closed (2)

Medical Condition

  • Show all (309)
  • Addiction (2)
  • Autoimmune Disorders (1)
  • Blood Disorders (1)
  • Cancer (41)
    • Brain Cancer (25)
    • Breast Cancer (1)
    • (-) Leukemia (2)
    • Lung Cancer (3)
    • Lymphoma (1)
    • Skin Cancer (1)
  • COVID-19 (Coronavirus) (1)
  • Developmental Disorders (2)
  • Ear, Nose and Throat (3)
    • (-) Hearing Loss (2)
    • Loss of Smell (1)
  • Endocrine & Metabolic Disease (1)
  • Eye (1)
  • Healthy Volunteers (35)
  • Heart Disease (1)
  • Infectious Disease (1)
  • Neurological Disorders (174)
  • Obstetrics & Gynecology (2)
  • Pediatrics (10)
  • Psychiatric Disorders (29)
  • Stroke (1)
  • Transplant (2)
  • Vascular Conditions (1)
Displaying 1 - 4 of 4

Early Age-Related Hearing Loss Investigation (EARHLI)

Condition: Ear, Nose and Throat / Hearing Loss
Investigator: Justin Golub, MD, MS
Status: Currently Recruiting
Early Age-Related Hearing Loss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). Age-related hearing loss (ARHL) is the third most common chronic condition in older adults. The way Age-…
Read More

Speech Perception in Hearing Impaired Listeners

Condition: Ear, Nose and Throat / Hearing Loss
Investigator: Nima Mesgarani, PhD
Status: Currently Recruiting
The purpose of this study is to learn more about the mechanisms of hearing loss, specifically to learn how abnormalities in the brain may produce certain experiences that are common in patients with hearing loss. Individuals with hearing loss will be compared to individuals with normal hearing.
Read More

A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

Condition: Cancer / Leukemia
Investigator: Ran Reshef, MD
Status: Closed
Patients who will be receiving immune effector cell (IEC) therapy for the treatment of their cancer (leukemia) are being asked to participate in this study. IEC can produce a harmful side effect called Cytokine Release Syndrome (CRS). CRS involves a release of a large amount of proteins into the bloodstream. This may cause changes in blood pressure and…
Read More

A study of adding study drug Sorafenib to the usual treatment in children and teens with AML (Acute Myeloid Leukemia)

Condition: Cancer / Leukemia
Investigator: Alice Lee, MD
Status: Closed
This study is for children and teens who have been diagnosed with Acute Myeloid Leukemia (AML). AML is a cancer of the bone marrow, the spongy tissue inside the large bones of the body where blood cells are made. In AML, the bone marrow makes large numbers of immature white blood cells called blasts. These blast cells crowd out the normal cells of the bone…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science